Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 307

The DOI matches its Crossref record; 189 of the 189 references it cites were found in a registry or an index.

Role of the cGAS–STING pathway in systemic and organ-specific diseases

Open access
Skopelja-Gardner, Sladjana, An, Jie, Elkon, Keith B.·2022·Nature Reviews Nephrology

Abstract

Cells are equipped with numerous sensors that recognize nucleic acids, which probably evolved for defence against viruses. Once triggered, these sensors stimulate the production of type I interferons and other cytokines that activate immune cells and promote an antiviral state. The evolutionary conserved enzyme cyclic GMP–AMP synthase (cGAS) is one of the most recently identified DNA sensors. Upon ligand engagement, cGAS dimerizes and synthesizes the dinucleotide second messenger 2′,3′-cyclic GMP–AMP (cGAMP), which binds to the endoplasmic reticulum protein stimulator of interferon genes (STING) with high affinity, thereby unleashing an inflammatory response. cGAS-binding DNA is not restricted by sequence and must only be >45 nucleotides in length; therefore, cGAS can also be stimulated by self genomic or mitochondrial DNA. This broad specificity probably explains why the cGAS–STING pathway has been implicated in a number of autoinflammatory, autoimmune and neurodegenerative diseases; this pathway might also be activated during acute and chronic kidney injury. Therapeutic manipulation of the cGAS–STING pathway, using synthetic cyclic dinucleotides or inhibitors of cGAMP metabolism, promises to enhance immune responses in cancer or viral infections. By contrast, inhibitors of cGAS or STING might be useful in diseases in which this pro-inflammatory pathway is chronically activated. The cyclic GMP–AMP synthase (cGAS)–stimulator of interferon genes (STING) pathway not only is involved in host defence against infection but can lead to immune dysregulation. Here, the authors examine the biology and biochemistry of cGAS–STING and discuss its role in disease and potential approaches to therapeutic targeting. Cyclic GMP–AMP synthase (cGAS) is an evolutionarily conserved cytosolic nucleic acid sensor that synthesizes the cyclic dinucleotide second messenger 2′,3′-cyclic GMP–AMP (cGAMP), which engages stimulator of interferon genes (STING) to trigger the production of inflammatory cytokines, including type I interferons. Extracellular cGAMP is hydrolysed by transmembrane and soluble ectonucleotide pyrophosphatase/phosphodiesterase 1, and enters neighbouring cells via cGAMP importers. Transfer to adjoining and distant cells enables cGAMP to act as an immunotransmitter and modulate antiviral responses, antitumour immunity and tumour metastasis. Activation of cGAS–STING by genomic or mitochondrial self DNA has been implicated in numerous autoinflammatory, autoimmune and neurodegenerative diseases, cell senescence and ageing, as well as in acute and chronic kidney injury. The microbiome can stimulate or inhibit cGAS–STING via cGAS sensing of commensal DNA, microorganism-induced endogenous retroviruses, or self DNA released owing to infection-induced cell damage. These interactions can affect gut and skin homeostasis. Modulating the proteins involved in the activation of the cGAS–STING pathway and its regulators provides therapeutic opportunities to attenuate or enhance cGAS–STING-driven inflammatory responses. Cyclic GMP–AMP synthase (cGAS) is an evolutionarily conserved cytosolic nucleic acid sensor that synthesizes the cyclic dinucleotide second messenger 2′,3′-cyclic GMP–AMP (cGAMP), which engages stimulator of interferon genes (STING) to trigger the production of inflammatory cytokines, including type I interferons. Extracellular cGAMP is hydrolysed by transmembrane and soluble ectonucleotide pyrophosphatase/phosphodiesterase 1, and enters neighbouring cells via cGAMP importers. Transfer to adjoining and distant cells enables cGAMP to act as an immunotransmitter and modulate antiviral responses, antitumour immunity and tumour metastasis. Activation of cGAS–STING by genomic or mitochondrial self DNA has been implicated in numerous autoinflammatory, autoimmune and neurodegenerative diseases, cell senescence and ageing, as well as in acute and chronic kidney injury. The microbiome can stimulate or inhibit cGAS–STING via cGAS sensing of commensal DNA, microorganism-induced endogenous retroviruses, or self DNA released owing to infection-induced cell damage. These interactions can affect gut and skin homeostasis. Modulating the proteins involved in the activation of the cGAS–STING pathway and its regulators provides therapeutic opportunities to attenuate or enhance cGAS–STING-driven inflammatory responses.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41581-022-00589-6

Cites

189 of 189 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 189 references

Cited by

See all 307

Metadata

Authors
Skopelja-Gardner, S., An, J., & Elkon, K. B.
Venue
Nature Reviews Nephrology
Published
2022-06-22
Volume
18
Issue
9
Pages
558-572
ISSN
  • 1745-8323 (ISSN-L)
  • 1759-5061
  • 1759-507X
OpenAlex
W4283360769
Cited by
307
References
189
FWCI
5.69
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Role of the cGAS–STING pathway in systemic and organ-specific diseases. https://app.cochat.ai/papers/10.1038/s41581-022-00589-6
The paper
Skopelja-Gardner, S., An, J., & Elkon, K. B. (2022). Role of the cGAS–STING pathway in systemic and organ-specific diseases. Nature Reviews Nephrology. https://doi.org/10.1038/s41581-022-00589-6

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.